187 related articles for article (PubMed ID: 17341559)
1. Aromatase expression in uterine leiomyomata is regulated primarily by proximal promoters I.3/II.
Imir AG; Lin Z; Yin P; Deb S; Yilmaz B; Cetin M; Cetin A; Bulun SE
J Clin Endocrinol Metab; 2007 May; 92(5):1979-82. PubMed ID: 17341559
[TBL] [Abstract][Full Text] [Related]
2. High aromatase expression in uterine leiomyoma tissues of African-American women.
Ishikawa H; Reierstad S; Demura M; Rademaker AW; Kasai T; Inoue M; Usui H; Shozu M; Bulun SE
J Clin Endocrinol Metab; 2009 May; 94(5):1752-6. PubMed ID: 19240151
[TBL] [Abstract][Full Text] [Related]
3. CCAAT/enhancer binding protein beta regulates aromatase expression via multiple and novel cis-regulatory sequences in uterine leiomyoma.
Ishikawa H; Fenkci V; Marsh EE; Yin P; Chen D; Cheng YH; Reisterd S; Lin Z; Bulun SE
J Clin Endocrinol Metab; 2008 Mar; 93(3):981-91. PubMed ID: 18182446
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19).
Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Kasai T; Inoue M
J Clin Endocrinol Metab; 2002 Jun; 87(6):2540-8. PubMed ID: 12050211
[TBL] [Abstract][Full Text] [Related]
5. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture.
Bulun SE; Simpson ER; Word RA
J Clin Endocrinol Metab; 1994 Mar; 78(3):736-43. PubMed ID: 8126151
[TBL] [Abstract][Full Text] [Related]
6. Aromatase in endometriosis and uterine leiomyomata.
Bulun SE; Imir G; Utsunomiya H; Thung S; Gurates B; Tamura M; Lin Z
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):57-62. PubMed ID: 16024248
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.
Noble LS; Takayama K; Zeitoun KM; Putman JM; Johns DA; Hinshelwood MM; Agarwal VR; Zhao Y; Carr BR; Bulun SE
J Clin Endocrinol Metab; 1997 Feb; 82(2):600-6. PubMed ID: 9024261
[TBL] [Abstract][Full Text] [Related]
8. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate.
Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Inoue M
J Clin Endocrinol Metab; 2001 Nov; 86(11):5405-11. PubMed ID: 11701714
[TBL] [Abstract][Full Text] [Related]
10. Aromatase in aging women.
Bulun SE; Zeitoun K; Sasano H; Simpson ER
Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
[TBL] [Abstract][Full Text] [Related]
11. Aromatase expression in endometriosis.
Noble LS; Simpson ER; Johns A; Bulun SE
J Clin Endocrinol Metab; 1996 Jan; 81(1):174-9. PubMed ID: 8550748
[TBL] [Abstract][Full Text] [Related]
12. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women.
Agarwal VR; Ashanullah CI; Simpson ER; Bulun SE
J Clin Endocrinol Metab; 1997 Jan; 82(1):70-4. PubMed ID: 8989235
[TBL] [Abstract][Full Text] [Related]
13. Endocrine disorders associated with inappropriately high aromatase expression.
Bulun SE; Noble LS; Takayama K; Michael MD; Agarwal V; Fisher C; Zhao Y; Hinshelwood MM; Ito Y; Simpson ER
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):133-9. PubMed ID: 9365182
[TBL] [Abstract][Full Text] [Related]
14. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
15. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
Kao YC; Okubo T; Sun XZ; Chen S
Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
[TBL] [Abstract][Full Text] [Related]
16. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads.
Bulun SE; Rosenthal IM; Brodie AM; Inkster SE; Zeller WP; DiGeorge AM; Frasier SD; Kilgore MW; Simpson ER
J Clin Endocrinol Metab; 1994 Feb; 78(2):1616-21. PubMed ID: 8106605
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells.
Yin P; Lin Z; Cheng YH; Marsh EE; Utsunomiya H; Ishikawa H; Xue Q; Reierstad S; Innes J; Thung S; Kim JJ; Xu E; Bulun SE
J Clin Endocrinol Metab; 2007 Nov; 92(11):4459-66. PubMed ID: 17785366
[TBL] [Abstract][Full Text] [Related]
18. Regulation of aromatase expression in human ovarian surface epithelial cells.
Okubo T; Mok SC; Chen S
J Clin Endocrinol Metab; 2000 Dec; 85(12):4889-99. PubMed ID: 11134158
[TBL] [Abstract][Full Text] [Related]
19. Three different promoters control expression of the aromatase cytochrome p450 gene (cyp19) in mouse gonads and brain.
Golovine K; Schwerin M; Vanselow J
Biol Reprod; 2003 Mar; 68(3):978-84. PubMed ID: 12604651
[TBL] [Abstract][Full Text] [Related]
20. Regulation of aromatase gene expression in purified germ cells of adult male rats: effects of transforming growth factor beta, tumor necrosis factor alpha, and cyclic adenosine 3',5'-monosphosphate.
Bourguiba S; Chater S; Delalande C; Benahmed M; Carreau S
Biol Reprod; 2003 Aug; 69(2):592-601. PubMed ID: 12700195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
